Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate can...
Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer
About this item
Full title
Author / Creator
de Resende, Marina França , Vieira, Samantha , Chinen, Ludmilla Thomé Domingos , Chiappelli, Francesco , da Fonseca, Francisco Paulo , Guimarães, Gustavo Cardoso , Soares, Fernando Augusto , Neves, Ivan , Pagotty, Simone , Pellionisz, Peter A , Barkhordarian, Andre , Brant, Xenia and Rocha, Rafael Malagoli
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
TOP2A encodes for topoisomerase IIα, a nuclear enzyme that controls DNA topological structure and cell cycle progression. This enzyme is a marker of cell proliferation in normal and neoplastic tissues; however, little information is available about its expression in prostate cancer (PCa).
Immunohistochemistry (IHC) was automated using mouse mono...
Alternative Titles
Full title
Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_56d158665947481ab9420756bed151a4
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_56d158665947481ab9420756bed151a4
Other Identifiers
ISSN
1479-5876
E-ISSN
1479-5876
DOI
10.1186/1479-5876-11-36
